Humigent lands Series A for its life sciences AI intelligence layer
What's the deal? Humigent, an AI-native startup building an intelligence layer for life sciences, has closed a Series A round with participation from Z21 VenturesDealroom has a profile for this one. Try Dealroom → and First Ray Venture PartnersDealroom has a profile for this one. Try Dealroom →. The New Jersey company said the money will fund product development, expand its agentic solutions, and scale deployments across life sciences organisations.
What's the endgame? Humigent is built around a model-agnostic architecture aimed squarely at pharma and biotech. Its core is HumigentLM, a proprietary 30-billion-parameter language model, paired with specialised AI agents and a domain-specific context layer that turns fragmented enterprise data into traceable, auditable answers.
What led up to it? The company says HumigentLM outperforms frontier models including Claude, GPT, and Gemini on accuracy, cost, latency, and privacy in life sciences use cases. Rather than replace existing systems, its intelligence layer sits above platforms such as Snowflake, Databricks, Veeva, and Salesforce.
Who's behind it? Founder and chief executive officer Ram Sharma previously built Analytical WizardsDealroom has a profile for this one. Try Dealroom →, a life sciences analytics firm acquired by Definitive Healthcare in 2022. The leadership team includes SVP of Product Inna Glozman, formerly at Merck and Bayer, plus AI talent and capabilities acquired from Aristia AI.
Why now? Humigent's technology is already deployed with multiple customers across commercial analytics, field intelligence, medical affairs, forecasting, and market research. It cites growing demand from organisations moving beyond AI pilots toward governed, domain-specific systems embedded in daily workflows.
The signal: Sharma's pitch draws a line in enterprise AI. "The winners in enterprise AI will not be defined simply by who have access to the largest model," he said. "They will be defined by who owns the deepest domain intelligence and can turn it into trusted action" — a bet that vertical, industry-specific models can outmuscle general-purpose giants.
Read more: Business Insider
Image credit: Enzymlogic
